As shown for the basal CD133-expressing cells (i.e. those isolated from untreated HCC cell lines), the most consistent finding was the statistically significant overexpression of DNMT3A in both cell lines after TGF-β treatment. Here, PROM1 is linked to hepatocellular carcinoma.